FFL Flash Alerts - Will Latavius Murray rush over 39.5 yards against the Panthers?
FFL Flash Alerts - Will Latavius Murray rush over 39.5 yards against the Panthers?
Rinus VeeKay says he’s happy to stay with Ed Carpenter Racing for his second season but suggests he will have to change teams to become a championship contender.
There are a lot of ways to die in a pandemic and not end up a COVID stat. One is to be in fading health and not be able to get lifesaving care when needed.
Moderna (NASDAQ: MRNA) reported complete data for its coronavirus vaccine candidate, mRNA-1273, today. It also submitted its application for emergency use authorization to the Food and Drug Administration (FDA). Investors will have to wait a few weeks to see what the agency thinks of the data package.
Japan plans to temporarily cut its aviation fuel tax by 80% at most to help the airline industry, which is struggling with the impact of the coronavirus pandemic, the Kyodo news agency reported on Tuesday.
Moderna has applied for US emergency approval for its "very highly efficacious" COVID-19 vaccine after data showed it was 94.1 per cent effective.
SAN ANTONIO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Rackspace Technology™ (NASDAQ: RXT) (the “Company”) today announced the early tender results for its previously announced tender offer (the “Tender Offer”) to purchase for cash any and all of its outstanding 8.625% Senior Notes due 2024 (the “Notes”). The Tender Offer is subject to the terms and conditions set forth in the Offer to Purchase, dated November 16, 2020, relating thereto (the “Offer to Purchase”). As of the previously announced early tender deadline of 5:00 p.m., New York City time, on Monday, November 30, 2020 (the “Early Tender Time”), the Company has been advised by Global Bondholder Services Corporation, as Depositary for the Tender Offer, that $259,147,000 in aggregate principal amount, or approximately 49.91%, of the outstanding Notes had been validly tendered and not withdrawn in the Tender Offer. The withdrawal deadline relating to the Tender Offer occurred at 5:00 p.m., New York City time, on Monday, November 30, 2020. Notes previously tendered and not withdrawn and Notes that are tendered after the withdrawal deadline may not be withdrawn, except as required by law. The Tender Offer is scheduled to expire at 12:00 midnight, New York City time, on Monday, December 14, 2020 (the “Expiration Time”), unless extended or terminated earlier.Subject to the terms and conditions of the Tender Offer, the Company is accepting for purchase all Notes validly tendered and not validly withdrawn prior to the Early Tender Time, with the settlement date for such purchase expected to occur on or about December 1, 2020.Citigroup Global Markets Inc. is acting as the dealer manager (the “Dealer Manager”) for the Tender Offer. Global Bondholder Services Corporation is acting as the Depositary and the Information Agent for the Tender Offer. Questions regarding the Tender Offer should be directed to Citigroup Global Markets Inc. at (800) 558-3745 (toll-free) or (212) 723-6106 (collect). Requests for documentation should be directed to Global Bondholder Services Corporation at (212) 430-3774 (for banks and brokers) or (866) 470-3900 (for all others).This announcement is for informational purposes only. This announcement is not an offer to purchase or a solicitation of an offer to purchase the Notes. The Tender Offer is being made solely pursuant to the Offer to Purchase. The Tender Offer is not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Tender Offer to be made by a licensed broker or dealer, the Tender Offer will be deemed to be made on behalf of the Company by the Dealer Manager, or one or more registered brokers or dealers that are licensed under the laws of such jurisdiction.None of the Company or its affiliates, the Dealer Manager, the Depositary, the Information Agent or the trustee with respect to the Notes is making any recommendation as to whether holders should tender any Notes in the Tender Offer, and neither the Company nor any such other person has authorized any person to make any such recommendation. Holders must make their own decision as to whether to tender any of their Notes, and, if so, the principal amount of Notes to tender.About Rackspace Technology Rackspace Technology is a leading end-to-end multicloud technology services company. We design, build and operate our customers’ cloud environments across all major technology platforms, irrespective of technology stack or deployment model. We partner with our customers at every stage of their cloud journey, enabling them to modernize applications, build new products and adopt innovative technologies.Rackspace Technology Safe Harbor StatementSome of the statements in this news release constitute “forward-looking statements” that do not directly or exclusively relate to historical facts. The forward-looking statements made in this release reflect the Company’s intentions, plans, expectations, assumptions and beliefs about future events and are subject to risks, uncertainties and other factors, many of which are outside of the Company’s control. Known risks include, among others, the risks included in Rackspace Technology, Inc.’s filings with the U.S. Securities and Exchange Commission. Because actual results could differ materially from the Company’s intentions, plans, expectations, assumptions and beliefs about the future, you are urged to view all forward-looking statements contained in this press release with caution. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.IR ContactJoe Crivelli Rackspace Technology Investor Relations IR@rackspace.comPR ContactNatalie Silva Rackspace Technology Corporate Communications firstname.lastname@example.org
Commissioner Margaret McMurdo identified grave and shocking failures in the informer relationship between Nicola Gobbo and Victoria Police.
The video conferencing specialist's stock has surged more than 562% so far in 2020, so even the latest quarter's stellar results weren't enough to keep the stock from slipping.
The British empire that owns Topshop, Topman and several other brands is seeking a new buyer.
The communications minister has fired off a letter to the ABC chair asking her to justify the broadcaster airing a program alleging poor behaviour by ministers.
Mainland China reported 12 new COVID-19 cases on Nov. 30, down from 18 cases a day earlier, the country's national health authority said on Tuesday. The National Health Commission said in a statement eight of the new cases were imported infections originating from overseas. The number of new asymptomatic cases, which China does not classify as confirmed cases, fell to five from 17 cases a day earlier.
Dick Johnson Racing boss Ryan Story has been named Chair of the Australian Motor Racing Commission.
NJR earnings call for the period ending September 30, 2020.
Increase in women population, penetration of Korean culture in Malaysia, and surge in women working population drive the growth of the Malaysia skin care market. The supermarket/hypermarket segment dominated the market in 2019, accounting for nearly one-third of the market. Moreover, lack of raw materials for the manufacturing of luxury cosmetics and the disrupted supply chain have created a shortage of supply of cosmetics.portland, OR, Nov. 30, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the Malaysia skin care market was pegged at$804.5 million in 2019, and is anticipated to garner $1.28 billion by 2027, growing at a CAGR of 8.1% from 2021 to 2027.Increase in women population, penetration of Korean culture in Malaysia, and surge in women working population drive the growth of the Malaysia skin care market. However, high price sensitivity and Halal consumerism hamper the market growth. On the contrary, increase in demand for skincare products with safe & sustainable ingredients and surge in penetration of digital technology are expected to create lucrative opportunities for the market players in the future.In-depth analysis of the COVID-19 impact on the Malaysia skin care Market@ https://www.alliedmarketresearch.com/request-for-customization/7012?reqfor=covidCovid-19 scenario: * To curb the spread of the Covid-19 virus, governments of several countries have banned international travel and imposed restrictions on imports and export. * Since the Covid-19 pandemic, the retail business is closed and the beauty, personal care, and cosmetic sectors are severely affected. * Moreover, lack of raw materials for the manufacturing of luxury cosmetics and the disrupted supply chain have created a shortage of supply of cosmetics. The Malaysia skin care market is segmented on the basis of type, demographics, age group, and distribution channel.Based on type, the market is categorized into cream, lotion, and others. The cream segment held the largest share in 2019, accounting for more than half of the market. However, the lotions segment is estimated to register the highest CAGR of 8.9% during the forecast period.Download Sample Copy Of Report@ https://www.alliedmarketresearch.com/request-sample/7012On the basis of demographics, the market is classified into male and female. The female segment held the largest share in 2019, contributing to nearly three-fifths of the market. However, the male segment is estimated to manifest the highest CAGR of 9.23% from 2020 to 2027.Based on age group, the market is divided into supermarket/hypermarket, specialty stores, department stores, beauty salons, pharmacies & drug stores, and online sales channels. The supermarket/hypermarketsegment dominated the market in 2019, accounting for nearly one-third of the market. However, the online sales channel segment is anticipated to register the highest CAGR of 10.61% during the forecast period.Send me enquire HEre@ https://www.alliedmarketresearch.com/purchase-enquiry/7012The Malaysia skin care market report includes an in-depth analysis of the major market players such as the Procter & Gamble Company, L'Oréal Group, Bejesdorf AG, Unilever PLC,Estee Lauder Companies Inc., Berjaya Corporation Berhad, Wipro Ltd., Alticor Inc., Shiseido Company Limited, and Avon Products Inc.Avenue Basic Plan | Library Access | 1 Year Subscription | Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starterGet more information: https://www.alliedmarketresearch.com/library-accessAbout Us:Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. CONTACT: Contact: David Correa 5933 NE Win Sivers Drive 205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-446-1141 International: +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 email@example.com Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research/
The global polypropylene market size was surpassed at US 114.77 bn in 2019 and expected to rake USD 173.49 bn by 2027, with a CAGR of 5.3% from 2020 to 2027.OTTAWA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- In 2019, the global volume of polypropylene market stood at nearly 72.03 Million Tons and expected to register a growth rate of nearly 4.5% over the forecast period. Polypropylene is basically a thermoplastic material that is prominently used for manufacturing fibers and molded materials. It provides excellent chemical and mechanical resistance coupled with translucent features. Excellent stiffness, lightweight, and flexibility properties offered by the product are the major trends and are significantly promoting the market growth over the upcoming years. In addition to these factors, they are notably used in various end-use industries such as automotive, agriculture, packaging, construction, electrical & electronics, and many others.Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1153Growth FactorsIncreasing demand of polypropylene from various end-use sectors such as automotive, packaging, healthcare, building & construction, and electrical & electronics attributed as the primary factors that drives the growth of the product. Features of polypropylene such as low-cost and excellent mechanical strength along with moldability are the major factors due to which more than half of the plastics used in the automotive sector are polypropylene. Polypropylene is used in various parts of an automobile, such as instrumental panels, bumpers, and door trims.Furthermore, the properties of polypropylene that include lightweight, low density, durability, high heat resistance, and high clarity make it a suitable for packaging applications. Polypropylene is also used significantly in the electrical & electronics and building & construction for the insulation of building wrap as well as electronics goods.However, rising environmental concern and government regulations for banning the use of plastic products expected to hamper the market growth in the upcoming years. Furthermore, there are number of substitutes available for the polypropylene such as polyethylene terephthalate (PET), polyethylene (PE), polyvinyl chloride (PVC), and many other that again restricts the market growth in the coming years.View full Report with Complete ToC@ https://www.precedenceresearch.com/polypropylene-marketRegional SnapshotsThe Asia Pacific captured major share in the market revenue accounting for nearly half of the market value in 2019 and further expected to growth prominently throughout the forecast timeframe. The remarkable growth of the region is mainly attributed to the increasing demand of polypropylene from packaging, automotive, medical, and building & construction sectors. The region is a growing market place for all the aforementioned industries owing to large consumer base and high growth in the disposable income of consumers that in turn attributed as a prime factor for the market growth for polypropylene in the region. In addition to this, supportive government policies for light weight electronics and automotive parts in order to control the rising environmental pollution again boost the demand for the product over the upcoming period.Moreover, North America and Europe are the prominent regions that hold nearly 30-35%market value collectively in the year 2019. Growing packaging and automotive industry in the regions are the main factors supporting the rapid growth of the market in the regions. Rising trend for packaged foods and drinks because of hectic lifestyle again triggers the growth of the polypropylene packaging solutions in these regions.Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1153Key Players & StrategiesThe global industry for polypropylene witnesses intense competition among the market players owing to the presence of large number of small and medium sized players. Furthermore, these industry participants are significantly involved in the forward integration of value chain process that results in the continuous supply of raw materials as well as this reduces the overall manufacturing cost. In addition to forward integration, the market players also invest prominently in the research & development (R&D) sector to excel their product specification coupled with the market reach.Some of the key players operating in the market are Lyondellbasell Industries Holdings B.V., Exxon Mobil Corporation, SABIC, China Petrochemical Corporation, Eastman Chemical Company, BASF SE, LG Chem, Trinseo S.A., Total S.A, and Westlake Chemical Corporation among others.Report Highlights * The Asia Pacific emerged as the market leader and accounted for a revenue share of approximately 50% in the year 2019 due to growing demand for polypropylene from packaging and automotive sectors * North America accounted for a value share of 16% in 2019 owing to its rising application for packaging in the food & beverage industry * By type, homopolymer dominated the global polypropylene market and accounted for around 83% revenue share in the year 2019 * Increasing demand for copolymer polypropylene in medical sector because of its toughness at low temperature along with higher stress crack resistance expected to drive its demand * Based on process, injection molding dominated the global market with a revenue share of around 37% in 2019 * Film & sheet accounted for the highest revenue share of nearly 36% in the global market in 2019 owing to its rising demand in boxes, binders, packaging materials, and portfolios * Fiber estimated to be the second largest application segment accounting for a value share of around 30% in 2019 because of rising demand from automotive industry Market SegmentationBy Process * Blow Molding * Extrusion * Injection Molding * OthersBy Type * Copolymer * HomopolymerBy Application * Film & Sheet * Raffia * Fiber * OthersBy End-use * Building & Construction * Electrical & Electronics * Automotive * Medical * Packaging * OthersBy Regional * North America * U.S. * Canada * Europe * U.K. * Germany * France * Asia Pacific * China * India * Japan * South Korea * Rest of the World Full Report is Ready | Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1153You can place an order or ask any questions, please feel free to contact at firstname.lastname@example.org | +1 774 402 6168About UsPrecedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.For Latest Update Follow Us:https://www.linkedin.com/company/precedence-research/
HALIFAX, Nova Scotia, Nov. 30, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2019. Profit and Loss Highlights * Revenue: The Company recorded revenues in FY2020 of $919,072 compared to $527,445 in FY2019. The increase in revenue was due to the Company’s additional revenues generated with the REVEALCOVID-19TM Total Antibody Test. * Gross Profit: The Company recorded a gross profit in FY2020 of $572,280 compared to $423,351 for the same period last year. * Operating expenses: In this financial year, the Company recorded operating expenses of $1,872,437 compared to $1,719,384 in FY2019. The increase of 9% in operating expenses were due to additional labour costs associated with the enhanced production for the Company’s REVEALCOVID-19TM Total Antibody Test. * Net loss: The Company recorded a net loss of $2,045,386 compared to $2,106,448 in FY2019.Balance Sheet Highlights * Assets: The Company had an expected increase of its assets by $3,143,557 compared to last financial year which was mainly due to the adoption of IFRS 16 which accounts for approximately $2.3m. IFRS 16, which was adopted by the Company in August 2019, changes the accounting requirement of how to recognize, measure, present and disclose leases. For MedMira, its leases are placed into assets and liabilities. * Liabilities: The Company’s liabilities increased by $5,188,943 or 38% between FY2019 and FY2020. This was mainly due to the adoption of IFRS 16 of approximately $2.3m. Furthermore, prepayments received from customers during this period in the amount of approximately $1.2m are considered deferred revenue and part of the current liabilities until these have been converted into revenue. * Loans in default slightly increased by $13,850 or 1% compared to the previous financial year. This increase was due to a related party’s loan being due in FY2020. All long and short terms debts are currently under negotiation to restructure terms and conditions of repayment. * Working Capital deficit: As a result of the increases noted above, the Company recorded higher working capital deficit of $1,371,642 or 10% compared to last financial year which was mainly due to an increase in deferred revenue (prepayment) of $1,240,890 from the Company’s distributors. These prepayments will be converted into revenue at the time of shipment.“In FY2020, MedMira was able to highlight the company’s adaptability to new global changes by developing a high-quality testing solution within a short time and which through repeated third-party testing demonstrated accuracy and ease of use. In addition, the company successfully ramped-up production to unprecedented levels without sacrificing stringent quality control measures,” said Markus Meile, CFO of MedMira Inc. “Whereas this new opportunity provided MedMira additional revenues and cash flow, other product sales had suffered during the third and fourth financial quarters, which was mainly due to the global lock downs and the market’s focus on COVID-19 testing. However, subsequent to the financial year end, these sales have steadily increased and will be reported in the following financial quarters.”Regulatory Status MedMira has applied to the US FDA to obtain FDA Emergency Use Authorization (EUA) for the REVEALCOVID-19™ Total Antibody Test, and its applications is under review. However, while awaiting the authorization, REVEALCOVID-19™ Total Antibody Test can be distributed in the U.S. according to Section IV.D of the Policy for Coronavirus Disease-2019 Test. In addition, MedMira received on the 21st of May 2020 the right to sell in all countries accepting CE mark. In Canada, the Company has re-submitted, based on the new template issued by Health Canada, its application on the 29th of October 2020. No sales can be made in Canada prior to receipt of the interim order from Health Canada.The Company’s financial statements and management’s discussion and analysis are available on the Company’s profile on SEDAR at www.sedar.com. For matters of going concern, reference is made to the Auditor’s Emphasis of Matter statement in the fiscal year ended 2020 Auditors Report and note 2b in the audited financial statements which are also available on SEDAR.About MedMiraMedMira is the developer and owner of Rapid Vertical Flow (RVF)® Technology. The Company’s rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and hepatitis C in just three easy steps. The Company’s tests are sold under the Reveal®, Multiplo® and Miriad® brands in global markets. MedMira’s corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada and the Company has a sales and customer service office located in the United States. For more information visit medmira.com. Follow us on Twitter and LinkedIn.This news release contains forward-looking statements, which involve risk and uncertainties and reflect the Company’s current expectation regarding future events including statements regarding possible approval and launch of new products, future growth, and new business opportunities. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.MedMira Contacts:Markus Meile, CFO Tel: 902-450-1588 Email: email@example.com
Liberty star Sabrina Ionescu shared a video of her getting shots up in the gym on Monday, and appears back to normal after undergoing ankle surgeryr.
Andrew Bogut has taken to his new podcast to announce his immediate retirement from basketball.
Asian stock markets faced a choppy session on Tuesday after Wall Street dipped as investors took profits at the end of a record-breaking month while still remaining upbeat about the prospect of a COVID-19 vaccine fuelling gains into next year. "U.S. markets were a little bit lower, that's what was holding us back a little bit," said Chris Weston, head of research at Melbourne brokerage Pepperstone. Hong Kong's Hang Seng index futures were down 0.36%.
The couple were married in front of friends in a traditional ceremony.